Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

J Dehn, S Spellman, CK Hurley… - Blood, The Journal …, 2019 - ashpublications.org
Allogeneic hematopoietic cell transplantation involves consideration of both donor and
recipient characteristics to guide the selection of a suitable graft. Sufficient high-resolution …

Exploitation of natural killer cells for the treatment of acute leukemia

R Handgretinger, P Lang… - Blood, The Journal of the …, 2016 - ashpublications.org
Natural killer (NK) cells play an important role in surveillance and elimination of malignant
cells. Their spontaneous cytotoxicity was first demonstrated in vitro against leukemia cell …

[HTML][HTML] Haploidentical natural killer cells infused before allogeneic stem cell transplantation for myeloid malignancies: a phase I trial

DA Lee, CJ Denman, G Rondon, G Woodworth… - Biology of Blood and …, 2016 - Elsevier
Allogeneic stem cell transplantation is an effective treatment for high-risk myeloid
malignancies, but relapse remains the major post-transplantation cause of treatment failure …

Influence of KIR and NK cell reconstitution in the outcomes of hematopoietic stem cell transplantation

F Gao, Y Ye, Y Gao, H Huang, Y Zhao - Frontiers in Immunology, 2020 - frontiersin.org
Natural killer (NK) cells play a significant role in immune tolerance and immune surveillance.
Killer immunoglobin-like receptors (KIRs), which recognize human leukocyte antigen (HLA) …

KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation

D Weisdorf, S Cooley, T Wang, E Trachtenberg… - Blood …, 2020 - ashpublications.org
Natural killer (NK) cell recognition and killing of target cells are enhanced when inhibitory
killer immunoglobulin-like receptors (KIR) are unable to engage their cognate HLA class I …

Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML

JA Fein, R Shouval, E Krieger, SR Spellman… - Blood …, 2024 - ashpublications.org
In acute myeloid leukemia (AML), donor natural killer cell killer immunoglobulin–like
receptors (KIR) and recipient HLA interactions may contribute to the graft-versus-leukemia …

Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia

MR Verneris, JS Miller, KC Hsu, T Wang… - Blood …, 2020 - ashpublications.org
Multiple models of donor killer immunoglobulin receptor (KIR) alloreactivity or KIR genotype
have been reported to be protective against leukemia relapse after allogeneic …

Reduction of relapse after unrelated donor stem cell transplantation by KIR-based graft selection

S Heidenreich, N Kröger - Frontiers in immunology, 2017 - frontiersin.org
Besides donor T cells, natural killer (NK) cells are considered to have a major role in
preventing relapse after allogeneic hematopoietic stem cell transplantation (HSCT). After T …

Haplotype motif-based models for KIR-genotype informed selection of hematopoietic cell donors fail to predict outcome of patients with myelodysplastic syndromes or …

J Schetelig, H Baldauf, L Koster, M Kuxhausen… - Frontiers in …, 2021 - frontiersin.org
Results from registry studies suggest that harnessing Natural Killer (NK) cell reactivity
mediated through Killer cell Immunoglobulin-like Receptors (KIR) could reduce the risk of …

Natural killer cells in malignant hematology: A primer for the non-immunologist

GS Kannan, A Aquino-Lopez, DA Lee - Blood Reviews, 2017 - Elsevier
Natural killer cells were first described over 40 years ago, but the last 15 years has shown
tremendous progress in our understanding of their biology and our ability to manipulate …